SHELTON, Conn., Dec. 03, 2015 (GLOBE NEWSWIRE) -- 3GTMS announces that Jerry Rau has joined the company as Chief Operating Officer. Jerry brings more than 25 years of transportation and supply chain experience to 3GTMS.
“The entire 3G Team is excited about Jerry’s addition and we expect this will accelerate our go to market efforts significantly,” said Mitch Weseley, founder and CEO of 3GTMS. “With Jerry’s experience 3GTMS will expand our footprint in the market and extend the application of our 3rd Generation TMS vision,” said Weseley.
“I am very excited for the opportunity to work with Mitch Weseley and the team at 3GTMS,” said Rau. “3G-TM is by far the most comprehensive North American TMS solution in the market. We are well positioned to accelerate the growth that 3G has experienced and be recognized as the leading transportation solution in the market.”
About Mr. Rau
Prior to his arrival at 3GTMS, Jerry served as the President and CEO at Veraction (Previously Iron Data Transportation). Jerry has also served in various Executive positions at RedPrairie (JDA) including EVP of Product and Corporate Marketing, and was also responsible for Channel and Alliances. Prior to RedPrairie, Jerry led Field Operations at i2 Technologies (JDA) serving as Global VP of Field Ops. Other responsibilities included VP of Sales Operations for the Transportation Team, and leading the M&A Integration Team efforts through multiple acquisitions. He has also invested over 15 years on the Carrier/3PL side for various companies including Mayne Nickless, Day & Ross Transportation Group and Canadian Pacific. Jerry has an MBA from Dalhousie University in Halifax, Nova Scotia.
About 3GTMS
3GTMS delivers order to settlement transportation management software (3G-TM) for shippers, brokers and 3PLs focusing on simplifying the process of complex transportation management. Built as a single system, 3G-TM manages the full transportation lifecycle including: rating, routing (including multi-stop and pool distribution optimization), tendering, tracking, tracing and settlement. 3G-TM transportation execution software provides embedded optimization allowing you make better shipping decisions that harness opportunities and address daily challenges. This allows you to build and planning and execution. Deployment options include on premise, hosted and SaaS, adjust or re-plan for the best cost and routing outcome helping transportation managers make better decisions, harness new opportunities, achieve cost savings, streamline processes and address the daily challenges of transportation.
For more information, visit: www.3GTMS.com, [email protected] or call us at 1.203.513.9336.
Media Contact: Stephen Gaines 3GTMS, Inc. 203.242.7942 [email protected]


SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 



